Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemia
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Cancer precision medicine. Karolinska Inst, Dept Med Solna, Div Clin Epidemiol, Stockholm, Sweden..ORCID iD: 0000-0001-6158-3041
Univ Haifa, Sch Publ Hlth, Haifa, Israel.;Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN USA..
Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN USA..
Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden..
Show others and affiliations
2024 (English)In: eJHaem, E-ISSN 2688-6146, Vol. 5, no 5, p. 998-1004Article in journal (Refereed) Published
Abstract [en]

Background

Chronic lymphocytic leukemia (CLL) is a heterogeneous disease. Whereas some patients have an indolent disease, others experience an aggressive course and early death. Our aim was to investigate if modifiable and non-modifiable medical history and lifestyle factors prior to diagnosis had an impact on the natural course of the disease.

Method

In 1154 CLL patients, we assessed if the weight, physical activity, smoking, and alcohol consumption or non-modifiable characteristics including family history of lymphoid malignancy and medical history were associated with time-to-first-treatment (TTFT) and adjusted all results for the CLL-International Prognostic Index (CLL-IPI).

Results

TTFT was shorter for patients with high/very high-risk CLL-IPI than those with low/intermediate risk CLL-IPI. In the adjusted analysis we did not find additional impact on TTFT besides CLL-IPI from any environmental characteristics assessed.

Conclusions

We found limited impact of environmental factors on the natural course of CLL (measured as the TTFT in treatment na & iuml;ve patients) providing valuable knowledge, and potential relief, to share with patients at the time of diagnosis. How patients have lived their life (i.e. degree of physical activity, smoking and alcohol consumption) has no impact on the natural course of chronic lymphocytic leukemia (CLL), measured as time to first treatment, while CLL-international prognostic index (IPI) and its components strongly predicts prognosis. image

Place, publisher, year, edition, pages
John Wiley & Sons, 2024. Vol. 5, no 5, p. 998-1004
Keywords [en]
chronic lymphocytic leukemia, CLL-IPI, environmental factors, family history, IGHV mutation status, time-to-first-treatment
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-548061DOI: 10.1002/jha2.1000ISI: 001298239400001PubMedID: 39415908OAI: oai:DiVA.org:uu-548061DiVA, id: diva2:1929656
Funder
Swedish Research Council, 2022-00801Swedish Cancer Society, 19 0123 Pj 01 HKnut and Alice Wallenberg FoundationSwedish Research CouncilSwedish Cancer Society, 190109SCIASwedish National Institute of Public Health, R25 CA92049Swedish National Institute of Public Health, R01 AG58266Swedish National Institute of Public Health, P50 CA097274Swedish National Institute of Public Health, R01 CA92153Swedish National Institute of Public Health, R01 CA 200703Swedish National Institute of Public Health, R21CA256648Swedish Cancer Society, CAN 2012/774Swedish Cancer Society, 19 0425 Pj 01 HThe Cancer Research Funds of RadiumhemmetKarolinska Institute
Note

Ingrid Glimelius and Geffen Kleinstern contributed equally to the first authorship and Susan L. Slager and Karin E. Smedby contributed equally to the last authorship.

Available from: 2025-01-21 Created: 2025-01-21 Last updated: 2025-01-21Bibliographically approved

Open Access in DiVA

fulltext(1343 kB)171 downloads
File information
File name FULLTEXT01.pdfFile size 1343 kBChecksum SHA-512
f5c0a8f3d0969911eb57c13841cdf31623c5c3a133854c9706d02d712cad082c86488e1ccb8d573633d61ff51218d9411a520c2484fe7acad770d98583266c8f
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Glimelius, IngridMattsson, Mattias

Search in DiVA

By author/editor
Glimelius, IngridMattsson, Mattias
By organisation
Cancer precision medicine
In the same journal
eJHaem
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 173 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 277 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf